background image

Oncology Clinical Trials

Find clinical trials for oncology. Search for oncology clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

Community Services Navigation to Advance Health Equity in Breast Cancer Screening

for
Breast Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06305312

Recruiting
Active & Responsive

Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

for
Small-cell Lung Cancer
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04342429

Recruiting
Active & Responsive

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

for
Solid Tumor, Adult, Colorectal Cancer, Non-Small Cell Lung,
Location: Gilbert AZ, La Jolla CA, Los Angeles CA,
Sponsor: A2 Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT06682793

Phase1, Phase2, Recruiting
Active & Responsive

WBSI Guided Personalized Delivery of TTFields

for
GBM, Glioma Glioblastoma Multiforme, Tumor, Brain
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 22+

Code: NCT05086497

Recruiting
Active & Responsive

Intraoperative OCT Guidance of Intraocular Surgery II

for
Macular Holes, Epiretinal Membrane, Diabetic Retinopathy,
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 0+

Code: NCT03713268

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors

for
Cancer-related Problem/Condition, Fatigue in Cancer Survivors,
Location: New York NY
Sponsor: 5 Point App, Inc.

Sex: All

Age: 18+

Code: NCT06754722

Recruiting
Active & Responsive

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Tucson AZ, San Diego CA, Denver CO, New Haven CT,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05216432

Phase1, Recruiting
Active & Responsive

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

for
Breast Cancer Screening, Breast Carcinoma in Situ,
Location: Birmingham AL, Irvine CA, Los Angeles CA, Sacramento CA,
Sponsor: University of California, San Francisco

Sex: Female

Age: 30 - 70+

Code: NCT02620852

Recruiting
Active & ResponsiveNew

Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

for
Hematologic Malignancies
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18 - 70+

Code: NCT07285668

Recruiting
Active & ResponsiveNew

FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors

for
Solid Tumor
Location: Portland OR
Sponsor: Axcynsis Therapeutics Pte Ltd

Sex: All

Age: 18+

Code: NCT06809114

Phase1, Recruiting

What are clinical trials for cancer?

Types of cancer clinical trials

Who can participate in oncology trials?

How to enroll in a clinical trial for cancer